Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer

Exploring ERBB2-related pathways will help us finding sensitive molecules and potential combined therapeutic targets of ERBB2-targeted therapy for ERBB2+ gastric cancer (GC). In this study, we performed a cross-databases study focused on ERBB2+ GC. The data of ERBB2+ GC deposited in the cancer genom...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Zhen, Huang, Xia, Wang, Jiexuan, Zhang, Jun, Ji, Jun, Yan, Ranlin, Zhu, Zhenggang, Cai, Wei, Yu, Yingyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085474/
https://www.ncbi.nlm.nih.gov/pubmed/30123134
http://dx.doi.org/10.3389/fphar.2018.00861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085474/
https://www.ncbi.nlm.nih.gov/pubmed/30123134
http://dx.doi.org/10.3389/fphar.2018.00861

Ejemplares similares